Issue Date: May 26, 2014
Diabetes-Related Enzyme Modulates Insulin, Amylin, And Glucagon
Scientists have wondered for decades whether slowing the degradation of insulin in the body might be a way to treat type 2 diabetes. The gene that encodes a zinc metalloprotease called insulin-degrading enzyme (IDE) was identified several years ago as a diabetes susceptibility gene. David R. Liu and Alan Saghatelian of Harvard University and coworkers have now discovered from a DNA-templated macrocycle library a potent, highly selective, and . . .
To view the rest of this content, please log in with your ACS ID.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © American Chemical Society